Elox-SOLOpharm

Indications for use
Initial therapy and short-term symptomatic treatment in:
- osteoarthritis (arthrosis, degenerative joint diseases);
- rheumatoid arthritis, ankylosing spondylitis;
- other inflammatory and degenerative diseases of the musculoskeletal system, such as arthropathies, dorsopathies (for example, sciatica, low back pain, shoulder periarthritis, and others), associated with pain.
Therapeutic class:
Non-steroidal anti-inflammatory drug (NSAID)
INN
Meloxicam
Blow-Fill-Seal
Market authorization in the following countries
Azerbaijan
Tajikistan
Kyrgyzstan
Georgia